The multifactorial nature of Alzheimer's disease (AD) is now widely recognized, which has increased the interest in compounds that can address more than one AD-associated targets. Herein, we report the inhibitory activity on the human cholinesterases (acetylcholinesterase, hAChE and butyrylcholinesterase, hBChE) and on the AChE-induced β-amyloid peptide (Aβ) aggregation by a series of peptide derivatives designed by mutating aliphatic residues for aromatic ones. We identified peptide W3 (LGWVSKGKLL-NH 2 ) as an interesting scaffold for the development of new anti-AD multitarget-directed drugs. It showed the lowest IC 50 value against hAChE reported for a peptide (0.99 � 0.02 μM) and inhibited 94.2 % � 1.2 of AChEinduced Aβ aggregation at 10 μM. Furthermore, it inhibited hBChE (IC 50 , 15.44 � 0.91 μM), showed no in vivo toxicity in brine shrimp and had shown moderated radical scavenging and Fe 2 + chelating capabilities in previous studies. The results are in line with multiple reports showing the utility of the indole moiety for the development of cholinesterase inhibitors.